Test Price
2,800 AED✅ Home Collection Available
MN1 Gene Meningioma & MN1 Deficiency Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% analytical sensitivity through ISO‑certified processing
- Logistics Excellence: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection (available daily 8 AM–11 PM)
- Post‑test Support: Telephone consultation with a specialist to interpret results
- Insurance Verification: Direct pre‑approval check via WhatsApp at +971 54 548 731
Test Overview & Methodology
This advanced next‑generation sequencing (NGS) test analyzes the entire coding region of the MN1 gene to identify germline and somatic mutations predisposing to meningioma and MN1‑deficiency syndromes. Performed on DNA extracted from peripheral whole blood or dried blood spots (FTA cards), the assay delivers clinically actionable results in 3–4 weeks to guide oncologic surveillance and family risk assessment.
| Feature | Our Accredited Test | Closest Alternative |
|---|---|---|
| Molecular Precision | Full MN1 gene NGS with copy‑number analysis | Targeted PCR for selected hot‑spot mutations only |
| Methodology | Next‑Generation Sequencing (NGS) – Illumina® platform (LC‑MS/MS orthogonal validation when needed) |
Sanger sequencing (lower throughput, limited resolution) |
| Turnaround Time | 3–4 weeks from sample receipt | 6–8 weeks typical |
Physician Insight & Safety Protocols
“I have reviewed the analytical and clinical validity of this test. A pathogenic variant in the MN1 gene significantly elevates the lifetime risk of meningioma, but results must always be interpreted alongside full clinical evaluation and imaging. A negative sequence does not exclude non‑genetic causes; all treatment and surveillance decisions should be made collaboratively with the patient, oncologist, and genetic counsellor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID 9294403
Advisory: Medication and Clinical Decision Guidance
Do not discontinue or modify any prescribed medication without explicit consultation with your treating physician. This test informs cancer risk predisposition; it does not provide therapeutic direction on its own.
Exclusion Criteria & Emergency Red Flags
- Known allergy to phlebotomy supplies or adhesive – request a pre‑test consultation.
- Inability to provide a sufficient blood volume (pediatric/neonatal cases) – contact our lab for micro‑collection options.
- If you experience sudden severe headache, vision loss, or seizure after sample collection, seek immediate emergency care (998 for ambulance in UAE).
- Patients under 18 years must be accompanied by a legal guardian in compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. Will this test tell me if I definitely have or will get a meningioma?
This test identifies inherited genetic variants in the MN1 gene that significantly increase meningioma predisposition, but imaging and clinical consultation are still required. A positive result means you have a high‑risk variant, not a current tumor diagnosis. Your oncologist will use the result alongside MRI surveillance to detect any lesion early. A negative result reduces but does not eliminate baseline population risk, as other genes or environmental factors may still be involved.
2. Can I use a simple finger‑prick blood spot instead of a full vein draw?
Yes, the test accepts one drop of blood on an FTA card, which provides enough high‑quality DNA for NGS analysis. This option is particularly beneficial for patients with difficult veins or children. However, the FTA card must be collected and dried correctly to avoid degradation; our home collection team is trained for this. A venous whole blood sample remains the gold standard for maximum DNA yield, but FTA cards have been validated with identical diagnostic accuracy in our ISO‑accredited workflow.
3. How long does it take, and will my insurance cover the cost?
Results are delivered in 3 to 4 weeks from sample arrival, and we provide direct insurance billing verification via WhatsApp. Because this is a clinically indicated genetic test for hereditary cancer, most UAE comprehensive health plans and DHA‑registered insurers cover it when accompanied by an oncologist or geneticist referral. Send your insurance card and referral to +971 54 548 731 on WhatsApp, and we will verify pre‑approval within 2 working hours. Self‑pay price remains 2,800 AED.
UAE Regulatory & Data Privacy Adherence
Data Protection: All patient information is handled in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Results are transmitted via secure, encrypted channels and stored within the UAE.
Clinical Safety: Sample collection and medical protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our laboratory holds DHA accreditation and follows ISO‑15189 quality standards.
Clinical & Logistical Metadata
| Test Name | MN1 Gene Meningioma & MN1 Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (venous or dried blood spot [FTA card]) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina® platform; orthogonal validation by LC‑MS/MS when indicated |
| ICD-10-CM Code | Z15.09 |
| LOINC Code | 48018-6 |
| DHA Facility License & Laboratory Address | DNA Labs UAE — License No. 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians